1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Distribution Channel ,Purchasing Pattern - Global Forecast to 2025

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Distribution Channel ,Purchasing Pattern - Global Forecast to 2025

  • December 2020
  • 193 pages
  • ID: 5823561
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The growth of this market is driven significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number of sports injuries. Also, the preference for personalized medicines for osteoarthritis, coupled with collaborations for product development to offer an opportunity for the growth of the market during the forecast period.

Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020.
Based on anatomy, the market is segmented into knee, hip, hand, and small-joint osteoarthritis therapeutics.Knee osteoarthritis therapeutics is the largest and the fastest-growing segment in this market.

This can primarily be attributed to the high incidence of knee osteoarthritis.

Viscosupplementation agents is expected to hold the largest share of the osteoarthritis therapeutics market, in 2020.
Based on drug type, the market is classified as, viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids.The analgesics segment is subsegmented into duloxetine and acetaminophen, while the NSAIDs segment is subsegmented into naproxen, aspirin, diclofenac, ibuprofen, and other NSAIDs.

The viscosupplementation agents segment accounted for the largest share of the osteoarthritis therapeutics market in 2019.The rising incidence of knee osteoarthritis is the major factor driving the growth of this segment.

Viscosupplementation effectively eases the pain of osteoarthritis through injections that fill up the joint’s synovial fluid, thus offering better lubrication of the joints.

Parental route is expected to hold the largest share of the osteoarthritis therapeutics market in 2020.
On the basis of route of administration, the osteoarthritis therapeutics market has been segmented into oral, topical, and parenteral routes.The parenteral route accounted for the largest share of this market in 2019 and is estimated to grow at the highest CAGR during the forecast period.

This can be attributed to the wide adoption of the parenteral route for administering osteoarthritis therapeutics owing to the ease of administration and the better pharmacokinetics and pharmacodynamics, resulting in better patient compliance.

Hospital pharmacies segment commanded the largest share of the osteoarthritis therapeutics market in 2020.
Based on the distribution channel, the osteoarthritis therapeutics market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.In 2019, hospital pharmacies accounted for the largest share of this market because of the high volume of patients visiting hospitals for osteoarthritis treatments and the wide range of osteoarthritis therapeutics available in these pharmacies.

Reimbursements can also be claimed easily on hospital pharmacy purchases, which is another important draw.

Prescription drugs segment commanded the largest share of the osteoarthritis therapeutics market in 2020.
Based on the purchasing pattern, the osteoarthritis therapeutics market is segmented into OTC and prescription drugs. In 2019, the prescription drugs segment accounted for a larger share of this market as most osteoarthritis therapeutics (viscosupplementation agents and corticosteroids) are only available on prescription.

Europe commanded the largest share of the osteoarthritis therapeutics market in 2020.
On the basis of region, the osteoarthritis therapeutics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.In 2019, Europe commanded the largest share of the osteoarthritis therapeutics market.

The large share of this market segment can be attributed to the rising incidence of osteoarthritis, rising geriatric population, and increasing obesity rates in several European countries, coupled with the rising number of injuries due to sports and road accidents.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), AsiaPacific (25%), Middle East and Africa (5%) and Latin America (11%)

The some of the major players operating in this market are Sanofi AG (France), Horizon Therapeutics plc (Ireland) and Pfizer, Inc. (US)

List of Companies Profiled in the Report
• Sanofi (France)
• Horizon Therapeutics PLC (Ireland)
• Johnson & Johnson (US)
• GlaxoSmithKline PLC (UK)
• Bayer AG (Germany)
• Abbott (US)
• Pfizer, Inc. (US)
• Eli Lilly (US)
• Anika Therapeutics, Inc. (US)
• Novartis AG (Switzerland)
• Ferring Pharmaceuticals (Switzerland)
• Bioventus (US)
• Zimmer Biomet Holdings, Inc. (US)
• Fidia Farmaceutici s.p.a. (Italy)
• Flexion Therapeutics, Inc. (US)
• Pharmed Limited (India)
• Virchow Biotech (India)
• Kitov Pharmaceuticals Ltd. (Israel)
• Assertio Therapeutics, Inc. (US)
• Atnahs (UK)
• Almatica Pharma LLC (US)
• OrthogenRx (US)
• LABRHA (France)
• Hanmi Pharm. Co., Ltd. (Korea)
• Laboratorio Reig Jofre (Spain)

Research Coverage
This report studies the osteoarthritis therapeutics market based on anatomy, drug type, route of administration, prescription pattern, distribution channel, and region.The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth.

It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total osteoarthritis therapeutics market.

The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on osteoarthritis therapeutics offered by the top 25 players in the osteoarthritis therapeutics market. The report analyzes the osteoarthritis therapeutics market by anatomy, drug type, route of administration, prescription pattern, distribution channel, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the osteoarthritis therapeutics market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the osteoarthritis therapeutics market

Frequently asked questions
• What are the growth opportunities in the osteoarthritis therapeutics market across major regions in the future?
• Which type of drug is expected to hold the largest share in the osteoarthritis therapeutics market?
• Which is the most preferred route of administration of osteoarthritis medications?
• Which region has a well-developed osteoarthritis therapeutics market?
• What is the impact of COVID-19 on osteoarthritis therapeutics market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • October 2020
  • 50 pages

“Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A ...

  • Japan
  • Spain
  • Arthritis
  • Immunotherapy
  • Industry analysis
  • Health Expenditure

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on